Adherence to Desvenlafaxine Versus Usual Care and Its Impact on Health Outcomes: A Comparative Real-world Clinical Study.
Narcís CardonerAntoni Sicras MainarJavier Rejas-GutierrezBeatriz ArmadaPublished in: Clinical drug investigation (2021)
Desvenlafaxine is significantly associated with a higher adherence rate at 12 months compared to usual care based on SSRI or other SNRI. This suggests that desvenlafaxine could improve disease management having a positive impact on disease-associated costs.